UK Obesity Research Institute
Ref: GRT-UKKGFI7A
Funding Available
Up to £60,000,000
UK Wide
Life Sciences & Health
19 November 2026
Grants & Funding
About This Grant
Director-led applications to investigate mechanistic biomedical drivers of obesity and related cardiometabolic disease and deliver transformative impact in obesity research. The director, supported by a leadership team, will lead the design and delivery of a collaborative institute focusing on key barriers to unlock understanding of the causes and consequences of obesity to enable targeted prevention and treatment.
What Can It Fund?
- Research
- Collaborative institute design and delivery
- Prevention and treatment research
Funding Source
Medical Research Council (MRC)
Explore More
Similar Grants
Chemical, biological, radiological and nuclear (CBRN) medical countermeasures R&D
Apply for funding to develop and test novel therapeutics, medical devices, diagnostics and other interventions across any stage of the developmental pathway, from prototype development, through pre-clinical refinement, to early-phase clinical studies (up to phase 2a) for CBRN threats. Applications must demonstrate how the proposed research will result in improved domestic preparedness for CBRN threats.
Invite only: Precision prevention: biological mechanisms of response variation
Apply for funding to investigate why biomedical prevention interventions work differently across people. Projects must generate mechanistic evidence in humans by testing biomedical experimental interventions or challenges in pre-disease or early disease states, providing insight into how to improve the targeting and effectiveness of precision prevention strategies.
Water4All 2026 call: sustainable water management
Funding for UK-based researchers to collaborate with international partners and submit joint applications for sustainable water management research.